Abstract
The development of commercial reagents designed specifically for use with formalin-fixed paraffin-embedded (FFPE) tissue has unlocked the diagnostic potential of this prolific resource. The availability of archival FFPE tissue and tissue from current patients make it an ideal resource for molecular testing. Despite its stability and ability to preserve morphological information, FFPE provides a number of technical challenges to the study of biomolecules. In particular, the cross-linking and processing present problems in the extraction and isolation of DNA, RNA and protein and affect their use in downstream analysis. Here we will discuss some of the problems of FFPE tissue, how they can be overcome and how FFPE material can be used within clinical molecular diagnostics.
Keywords: Biomarkers, BRAF, EGFR, FFPE tissue, FFPE diagnostics, HER2, KRAS, molecular diagnostics, molecular pathology, personalised medicine, targeted therapy.
Current Drug Targets
Title:Making the Most of Pathological Specimens: Molecular Diagnosis in Formalin-Fixed, Paraffin Embedded Tissue
Volume: 13 Issue: 12
Author(s): Jennifer A. Fairley, Katelyn Gilmour and Kathy Walsh
Affiliation:
Keywords: Biomarkers, BRAF, EGFR, FFPE tissue, FFPE diagnostics, HER2, KRAS, molecular diagnostics, molecular pathology, personalised medicine, targeted therapy.
Abstract: The development of commercial reagents designed specifically for use with formalin-fixed paraffin-embedded (FFPE) tissue has unlocked the diagnostic potential of this prolific resource. The availability of archival FFPE tissue and tissue from current patients make it an ideal resource for molecular testing. Despite its stability and ability to preserve morphological information, FFPE provides a number of technical challenges to the study of biomolecules. In particular, the cross-linking and processing present problems in the extraction and isolation of DNA, RNA and protein and affect their use in downstream analysis. Here we will discuss some of the problems of FFPE tissue, how they can be overcome and how FFPE material can be used within clinical molecular diagnostics.
Export Options
About this article
Cite this article as:
A. Fairley Jennifer, Gilmour Katelyn and Walsh Kathy, Making the Most of Pathological Specimens: Molecular Diagnosis in Formalin-Fixed, Paraffin Embedded Tissue, Current Drug Targets 2012; 13 (12) . https://dx.doi.org/10.2174/138945012803530125
DOI https://dx.doi.org/10.2174/138945012803530125 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Focal Adhesion Kinase: From In Vitro Studies to Functional Analyses In Vivo
Current Protein & Peptide Science The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair
Current Vascular Pharmacology Combating Obesity by Targeting Nuclear Receptors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction
Current Pharmaceutical Design The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Current Protein & Peptide Science Sudden Infant Death Syndrome from Epidemiology to Pathophysiology
Current Pediatric Reviews An Old Drug with a New Purpose: Cardiovascular Actions of Acetaminophen (Paracetamol)
Current Drug Targets - Cardiovascular & Hematological Disorders Patent Selections
Recent Patents on Regenerative Medicine Diabetic Cardiomyopathy: Clinical and Metabolic Approach
Current Vascular Pharmacology Inflammatory Biomarkers and Therapeutic Targets in Heart Failure
Current Medicinal Chemistry Cell Therapy for Myocardial Regeneration
Current Molecular Medicine Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease
Current Drug Targets Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Current Stem Cell Research & Therapy Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Current Cardiology Reviews Radionuclide PET and PET/CT in Coronary Artery Disease
Current Pharmaceutical Design Exercise-induced Physiological Hypertrophy: Insights from Genomics
Current Genomics MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Advanced Glycation End Products: A Link Between Periodontitis and Diabetes Mellitus?
Current Diabetes Reviews Geriatric Psychopharmacology in Acute Settings
Current Psychopharmacology